Trial patients lost up to 25% of body weight on the top dose, while Lilly warns that any retatrutide sold outside its trials is illegal and unverified.
Recap by typeshit. Full story at Newsweek.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A short clip from Dr Nadolsky on tiredness while taking GLP-1 medication and what he suggests people look at to ease it.
The nutrition account flags muscle loss on GLP-1 drugs and why it matters for metabolism, strength, blood sugar and aging.
Loading…